Candidate for Region IV: Regional Director
1. What are your greatest contributions to ASAM and the field of addiction medicine?
My interest in Addiction Medicine started with my Public Health Service obligation in Tuba City Arizona from 1986 to 1990. I was challenged by the severity of primarily alcohol use disorders among the Navajo and Hopi Native American tribes. As my CV reflects, I had varied experiences as Medical Director in Chemical Dependency Treatment Centers as well as Dual Disorder hospital based units, and outpatient IOP/Partial treatment programs as well. Several years ago after attending a Med-Sci meeting I discussed having greater involvement with ASAM, and initially was involved with the Patient Advocacy Task Force from 2013 through 2015. Subsequently I have had active involvement with the ASAM Payers Committee and the Pharmacy Lock In program ad hoc committee. I have served my State of NJ as Secretary of NJSAM and now as President of NJSAM. I also participate with the PCSS-MAT Providers Clinical Support System for Medication Assisted Treatment. I achieved ABAM certification last year.
My active involvement with ASAM has only been for the last few years, but I extremely passionate about the practice of Addiction Medicine. I primarily maintain a busy private practice of Addiction Medicine and Psychiatry and have been honored every year as one of South Jersey’s “Top Addiction Psychiatrist”. I am fully committed to addressing the barriers that impede patients’ and their family’s access to quality and timely treatment. I am involved with teaching and mentoring psychiatry residents, lecturing to the community and helping to train Physicians in the effective use of Medication Assisted Treatment approaches.
2. How would your election benefit ASAM and the field of addiction medicine?
I am running for Regional Director in order to accomplish the mission of improving access to effective treatment for those who suffer from the disease of chemical dependency. My overriding interest is working with ASAM leadership to remove barriers to timely and comprehensive treatment. Whether these impediments to treatment involve legislative biases, burdensome insurance and payer requirements and even the negative perceptions regarding addictive disorders that our communities and even patients maintain, I am passionate about dealing with these issues. In my work thus far with the Payers committee I volunteered to develop a template universal prior authorization form for Buprenorphine treatment that is now being discussed as one way to help physicians in their efforts to more easily obtain these lifesaving medications for their patients. I have met with legislators in New Jersey to advance addiction treatment related issues, both as a representative of the NJ Psychiatric Association and also representing NJSAM. I strongly believe that it is also very important for ASAM to take a leadership role in promoting best practices, and lecture extensively in this regard.
Dr. Shore completed his Medical training at Temple University Medical School in Philadelphia in 1980. He then attended Thomas Jefferson University and completed his 4 year general adult training in Psychiatry in 1984, serving as Chief Resident in his final year. Following two years as an attending at Jefferson, serving as director of the acute inpatient Unit and Acting Director of the Crises Center, he joined his wife and they both completed 4 years in the National Health Service Corps with the Indian Health Service in Arizona. From 1990 through 2002 Dr. Shore worked in various venues, including Director of the Inpatient Unit at Cooper University Hospital in Camden, NJ; Residency training director for Psychiatry at Cooper; Medical Director of the Malvern Institute, a drug and alcohol treatment facility; Chief of Substance Abuse Services at Hampton Hospital; and part time work in outpatient chemical dependency treatment programs at Rancocas Hospital and with Princeton House. Dr. Shore has maintained an outpatient private practice of Psychiatry and Addiction Medicine since 1993, and has been full time in his private practice since 2002. He also serves as the Medical Director for both Elm Lifelines, a women’s IOP program, and Lakeside Recovery Center in Sicklerville, NJ. Dr. Shore has received several “Top Doc” awards for South Jersey in Psychiatry and Addiction Medicine, including most recently in 2015. Dr. Shore was honored as the Addiction Medicine Physician of the Year for 2012 by New Jersey Society of Addiction Medicine. Dr. Shore currently holds the position of President of the NJ Society of Addiction Medicine. He was elected in 2015 as the Senior Vice President of the NJ Psychiatric Association and is the Chair of the NJPA Committee on Education. He also continues to serve on the NJPA Council on Advocacy. He was appointed to the NJ Psychiatric Association as a Trustee in 2013.
Dr. Shore has organized and chaired two CME programs jointly sponsored by NJPA and NJSAM, including “Buprenorphine 201 – Advanced Topics” in 2012, and most recently “Addiction Medicine 2014 – Hot Topics” in 2014.